Search - tctmd.com

Displaying 41 - 60 of 267

Sort: Relevancy | Date

Presentation TCT 2023

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

Presenter: Steven Yakubov

October 25, 2023

Presentation TCT 2023

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

Presenter: Guilherme Attizzani

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2023

TCT 32: Predicting Commissural Alignment for the Evolut Valve Using 3D Modeling and Printing

Presenter: Osama Elkhateeb

October 25, 2023

Presentation TCT 2023

TCT 663: The Evolution of Artificial Intelligence (AI) Capabilities in the Peripheral Endovascular Field

Presenter: Anthony Pham

October 24, 2023

Presentation TCT 2023

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

Presenter: Atsushi Okada

October 24, 2023

Presentation TCT 2023

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

Presenter: Kendra Grubb

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

The Emerging Era of Decentralized Care: Insights From a Novel Model of Remote Clinical Care Management

Presenter: Lou Silverman

October 23, 2023

Presentation TCT 2023

The Emerging Era of Diagnostic Assistance: Virtual Biopsy to Transform Skin Cancer Diagnosis (Enspectra Health)

Presenter: Gabriel Sanchez

October 23, 2023

Presentation TCT 2023

Enhancing the Prediction Capabilities of Implantable Devices: Current State and Future Opportunities

Presenter: Laura Mauri

October 23, 2023

Presentation TVT 2023

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

Presenter: Sachin Goel

June 10, 2023

Presentation TVT 2023

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Presenter: Wah Wah Htun

June 09, 2023

Presentation TVT 2023

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Presenter: Amit Vora

June 08, 2023

Presentation TVT 2023

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

Presenter: Firas Zahr

June 08, 2023

Presentation TVT 2023

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Presenter: Amit Vora

June 07, 2023

Presentation Fellows 2023

The Evolution in PCI Pharmacology: What You Need to Know

Presenter: Binita Shah

May 11, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation Miami Valves 2023

Evolution of ICD Therapy: 50 Years of Progress

Presenter: Sanjeev Saksena

February 03, 2023

Advertisement

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 32: Predicting Commissural Alignment for the Evolut Valve Using 3D Modeling and Printing

TCT 663: The Evolution of Artificial Intelligence (AI) Capabilities in the Peripheral Endovascular Field

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

Four-Year Outcomes From the EVOLUT Low Risk Trial

The Emerging Era of Decentralized Care: Insights From a Novel Model of Remote Clinical Care Management

The Emerging Era of Diagnostic Assistance: Virtual Biopsy to Transform Skin Cancer Diagnosis (Enspectra Health)

Enhancing the Prediction Capabilities of Implantable Devices: Current State and Future Opportunities

Case Presentation 1: Failed Supra-Annular TAVR and ‘How To Do’ TAV-in-TAV (Sapien in Evolut)

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Point: Technology Evolution of M-TEER Already Allows the Treatment of Complex Anatomies and Lower Risk Patients!

Late-Breaking Clinical Science: Three-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

The Evolution in PCI Pharmacology: What You Need to Know

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Evolution of ICD Therapy: 50 Years of Progress

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content